untitled
<OAI-PMH schemaLocation=http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd>
<responseDate>2018-01-15T18:33:14Z</responseDate>
<request identifier=oai:HAL:hal-00875077v1 verb=GetRecord metadataPrefix=oai_dc>http://api.archives-ouvertes.fr/oai/hal/</request>
<GetRecord>
<record>
<header>
<identifier>oai:HAL:hal-00875077v1</identifier>
<datestamp>2017-12-21</datestamp>
<setSpec>type:ART</setSpec>
<setSpec>subject:sdv</setSpec>
<setSpec>collection:UNIV-PARIS7</setSpec>
<setSpec>collection:UNIV-AG</setSpec>
<setSpec>collection:IFR140</setSpec>
<setSpec>collection:UNIV-RENNES1</setSpec>
<setSpec>collection:IRSET</setSpec>
<setSpec>collection:APHP</setSpec>
<setSpec>collection:IRSET-HIAEC</setSpec>
<setSpec>collection:BIOSIT</setSpec>
<setSpec>collection:UR1-UFR-SVE</setSpec>
<setSpec>collection:USPC</setSpec>
<setSpec>collection:UR1-HAL</setSpec>
<setSpec>collection:EHESP</setSpec>
<setSpec>collection:STATS-UR1</setSpec>
<setSpec>collection:UR1-SDV</setSpec>
<setSpec>collection:IRSET-2</setSpec>
<setSpec>collection:UNIV-ANGERS</setSpec>
</header>
<metadata><dc>
<publisher>HAL CCSD</publisher>
<title lang=en>Transmitted drug resistance in French HIV-2-infected patients.</title>
<creator>Charpentier, Charlotte</creator>
<creator>Visseaux, Benoit</creator>
<creator>Bénard, Antoine</creator>
<creator>Peytavin, Gilles</creator>
<creator>Damond, Florence</creator>
<creator>Roy, Céline</creator>
<creator>Taieb, Audrey</creator>
<creator>Chêne, Geneviève</creator>
<creator>Matheron, Sophie</creator>
<creator>Brun-Vézinet, Françoise</creator>
<creator>Descamps, Diane</creator>
<creator>Michelet, Christian</creator>
<contributor>Laboratoire de Virologie ; Assistance publique - Hôpitaux de Paris (AP-HP) - Hôpital Bichat - Claude Bernard [Paris]</contributor>
<contributor>Epidémiologie et Biostatistique [Bordeaux] ; Université Bordeaux Segalen - Bordeaux 2 - Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED) - Institut National de la Santé et de la Recherche Médicale (INSERM)</contributor>
<contributor>Service de pharmacie ; Assistance publique - Hôpitaux de Paris (AP-HP) - Hôpital Bichat - Claude Bernard [Paris]</contributor>
<contributor>Service des maladies infectieuses et tropicales ; Assistance publique - Hôpitaux de Paris (AP-HP) - Hôpital Bichat - Claude Bernard [Paris] - Université Paris Diderot - Paris 7 (UPD7)</contributor>
<contributor>Institut de recherche, santé, environnement et travail [Rennes] (Irset) ; Université d'Angers (UA) - Université des Antilles et de la Guyane (UAG) - Université de Rennes 1 (UR1) - École des Hautes Études en Santé Publique [EHESP] (EHESP) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )</contributor>
<description>International audience</description>
<source>ISSN: 0269-9370</source>
<source>AIDS</source>
<publisher>Lippincott, Williams & Wilkins</publisher>
<identifier>hal-00875077</identifier>
<identifier>https://hal.archives-ouvertes.fr/hal-00875077</identifier>
<source>https://hal.archives-ouvertes.fr/hal-00875077</source>
<source>AIDS, Lippincott, Williams & Wilkins, 2013, 27 (10), pp.1671-4. 〈10.1097/QAD.0b013e32836207f3〉</source>
<identifier>PUBMED : 23595155</identifier>
<relation>info:eu-repo/semantics/altIdentifier/pmid/23595155</relation>
<identifier>DOI : 10.1097/QAD.0b013e32836207f3</identifier>
<relation>info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0b013e32836207f3</relation>
<language>en</language>
<subject>[SDV.TOX] Life Sciences [q-bio]/Toxicology</subject>
<type>info:eu-repo/semantics/article</type>
<type>Journal articles</type>
<description lang=en>We report the first transmitted drug resistance survey study in HIV-2-infected patients living in France. The prevalence of transmitted drug resistance was 5.0% (95% confidence interval, 0.1-9.9) with mutations detected only in protease, not in reverse transcriptase. In this series, 10% of patients displayed X4/dual-mixed viruses. These findings classified the rate of transmitted drug resistance in the HIV-2 French Cohort as low prevalence.</description>
<contributor>ANRS CO5 HIV-2 Cohort</contributor>
<date>2013-06-19</date>
</dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
